129791-55-5

Basic information

• Product Name: 4-(2,3-dihydro-1,4-benzodioxine-6-carbonylamino)benzoic acid
• Synonyms: 4-(2,3-dihydro-1,4-benzodioxine-6-carbonylamino)benzoic acid
• CAS NO: 129791-55-5
• Molecular Formula: C₁₆H₁₃NO₅
• Molecular Weight: 299.27812
• Mol File: 129791-55-5.mol
• Article Data: 3

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 4-(2,3-dihydro-1,4-benzodioxine-6-carbonylamino)benzoic acid(CAS DataBase Reference)
• NIST Chemistry Reference: 4-(2,3-dihydro-1,4-benzodioxine-6-carbonylamino)benzoic acid(129791-55-5)
• EPA Substance Registry System: 4-(2,3-dihydro-1,4-benzodioxine-6-carbonylamino)benzoic acid(129791-55-5)

Safety Data

• Hazardous Substances Data: 129791-55-5(Hazardous Substances Data)

Upstream product

• 4442-54-0 2,3-dihydro-1,4-benzodioxin-6-carboxylic acid 
• 94-09-7 p-aminoethylbenzoate 

Relevant articles and documents

METHOD FOR PROCESSING 4-SUBSTITUTED BENZOIC ACID DERIVATIVES HAVING 3, 4-METHYLENE- OR 3,4-ETHYLENEDIOXYBENZENE MOIETY AND THE USE OF THE SAME FOR ANTIAGING COSMETICS

The present invention relates to a method for preparing 4-substituted benzoic acid derivatives having a 3, 4-methylenedioxybenzene or 3, 4-ethylenedioxybenzene backbone, and the use of the derivatives for antiaging cosmetics. More particularly, the invention relates to a method for preparing 4-substituted benzoic acid derivatives, which have a 3, 4-methylenedioxybenzene or 3, 4-ethylenedioxybenzene backbone and show the effect of stimulating the production of collagen, elastin, fibrillin and glycosaminoglycan, which are the main constituents of the skin's dermis, and to the use of the derivatives for antiaging cosmetics, which have the effect of reducing skin wrinkles.

Condensed heterocyclic compounds

The invention relates to compounds of the formula STR1 wherein R1 is hydrogen, acyl, lower-alkyl or --CHO, --CH2 OR10, --COR7 or OR13 ; R2, R3 and R4 are, independently, hydrogen, lower-alkyl, lower-alkoxy or halogen; R5 and R6 are, independently, hydrogen or lower-alkyl; R7 is hydroxy, lower-alkoxy or NR8 R9 ; R8 and R9 are, independently, hydrogen or lower-alkyl; X and Y are, independently, >CR14 R15, --O--, --S--, >SO, >SO2 or >NR18 ; R10 and R18 are, independently, hydrogen, lower-alkyl or acyl; M is --C(R11)=C(R12)--, --CONH-- or --NH--CO--; R11, R12, R14 and R15 are, independently, hydrogen or lower-alkyl, R13 is hydrogen, lower-alkoxycarbonyl or lower- alkyl, which can be substituted by amino, mono-alkylamino, di-alkylamino, morpholino, thiomorpholino or piperazino; and n is 1, 2, 3 or 4; with the proviso that at least one of X and Y comprises a hetero atom and n is 1, 3 or 4 when X contains a hetero atom, Y is >C(CH3)2 and R1 is lower-alkyl or --CH2 OR10 or --COR7, or a salt of a compound of formula I, when R1 is carboxy. The compounds of formula I are useful in the treatment of prophylaxis of neoplasms, dermatoses and ageing of the skin.